Adage Capital Management, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Fulcrum Therapeutics, Inc. Common Stock, par value $0.001 per share (FULC)

Filing Manager
Adage Capital Management, L.P.
Reporting Manager
Adage Capital Management, L.P.
Security
Fulcrum Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
FULC
Shares outstanding
54,044,444 shares
Disclosed Ownership
2,432,000 shares
Ownership
4.5%
Form type
SCHEDULE 13G/A
Filing time
13 Nov 2025, 09:03:53 UTC
Date of event
30 Sep 2025
Previous filing
12 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Adage Capital Management, L.P. disclosed 4.5% ownership in Fulcrum Therapeutics, Inc. Common Stock, par value $0.001 per share (FULC) on 30 Sep 2025."

Quick Takeaways

  • Adage Capital Management, L.P. filed SCHEDULE 13G/A for Fulcrum Therapeutics, Inc. Common Stock, par value $0.001 per share (FULC).
  • Disclosed ownership: 4.5%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 12 Aug 2025.
  • Current filing was accepted on 13 Nov 2025, 09:03.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 4.5% 2,432,000 0 2,432,000 /s/ Robert Atchinson By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Robert Atchinson 4.5% 2,432,000 0 2,432,000 /s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 4.5% 2,432,000 0 2,432,000 /s/ Phillip Gross Phillip Gross, individually

Sponsored